Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3

Am J Clin Nutr. 2004 Mar;79(3):510-5. doi: 10.1093/ajcn/79.3.510.

Abstract

Background: Elevated fasting plasma concentrations of complement component 3 (C3) are associated with elevated fasting and postprandial triacylglycerol concentrations, insulin resistance, obesity, and coronary artery disease. C3 is the central component of the complement system and the precursor of acylation-stimulating protein (ASP). Insulin and ASP are principal determinants of free fatty acid (FFA) trapping by adipose tissue.

Objective: Because controversy exists concerning postprandial changes in C3 and because meal composition may influence complement activation, we studied postprandial lipemia in relation to changes in plasma C3.

Design: After an overnight fast, 6 healthy men ( +/- SD age: 23 +/- 2 y) underwent 4 oral liquid challenges: fat (50 g/m(2) body surface), glucose (37.5 g/m(2)), fat and glucose (mixed test), and water (as a control test) in a random, crossover design.

Results: Plasma ASP concentrations did not change postprandially in any test. Changes in C3 concentration were observed only after the fat challenge: elevated concentrations occurred between 1 and 3 h, and a maximum increase of 11% occurred at 2 h (P = 0.05). Postprandial triacylglycerolemia did not differ significantly between the fat and mixed tests. The FFA response after the fat challenge was the highest of all the tests (P < 0.05 for all comparisons) and was accompanied by an increase in ketone bodies (maximum at 6 h); this increase did not occur after the mixed test, which suggests less hepatic FFA delivery.

Conclusions: When glucose is added to an oral fat load, the postprandial FFA response is reduced, and the fat-specific increase in C3 is prevented. After ingestion of fat without glucose, the lack of insulin response may lead to C3-mediated peripheral FFA trapping, which probably serves as a backup system in case of insufficient or inefficient insulin-dependent FFA trapping.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Area Under Curve
  • Blood Proteins / metabolism
  • Complement Activation
  • Complement C3 / metabolism*
  • Complement C3a* / analogs & derivatives*
  • Cross-Over Studies
  • Dietary Fats / administration & dosage*
  • Dietary Fats / metabolism
  • Fasting
  • Fatty Acids, Volatile / metabolism*
  • Glucose / administration & dosage*
  • Glucose / metabolism
  • Humans
  • Insulin / blood
  • Insulin Resistance
  • Ketone Bodies / metabolism
  • Male
  • Obesity / blood
  • Postprandial Period / physiology*
  • Triglycerides / blood

Substances

  • Blood Proteins
  • Complement C3
  • Dietary Fats
  • Fatty Acids, Volatile
  • Insulin
  • Ketone Bodies
  • Triglycerides
  • complement C3a, des-Arg-(77)-
  • Complement C3a
  • Glucose